Skip to main content

Main menu

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

User menu

  • Log in
  • Subscribe
  • Contact Us
  • My Cart

Search

  • Advanced search
  • ERS Publications
    • European Respiratory Journal
    • ERJ Open Research
    • European Respiratory Review
    • Breathe
    • ERS Books
    • ERS publications home

Login

European Respiratory Society

Advanced Search

  • Home
  • Current issue
  • ERJ Early View
  • Past issues
  • Authors/reviewers
    • Instructions for authors
    • Submit a manuscript
    • Open access
    • COVID-19 submission information
    • Peer reviewer login
  • Alerts
  • Podcasts
  • Subscriptions

Interstitial pulmonary fibrosis model develpment and identification of early biomarkers by MALDI imaging

Mary Mcelroy, David Bonnel, Emeline Falaux, Gael Picard de Muller, Fabien Pamelard, Claudio Petterino, Stuart Naylor, Stephen Madden, Jonathan Stauber
European Respiratory Journal 2015 46: PA4858; DOI: 10.1183/13993003.congress-2015.PA4858
Mary Mcelroy
1In Vivo Discovery, Charles River, Edinburgh, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
David Bonnel
2Mass Spectrometry Imaging, ImaBiotech, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Emeline Falaux
2Mass Spectrometry Imaging, ImaBiotech, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Gael Picard de Muller
2Mass Spectrometry Imaging, ImaBiotech, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Fabien Pamelard
2Mass Spectrometry Imaging, ImaBiotech, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Claudio Petterino
1In Vivo Discovery, Charles River, Edinburgh, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stuart Naylor
1In Vivo Discovery, Charles River, Edinburgh, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen Madden
1In Vivo Discovery, Charles River, Edinburgh, United Kingdom
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Jonathan Stauber
2Mass Spectrometry Imaging, ImaBiotech, Lille, France
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Info & Metrics
Loading

Abstract

Interstitial Pulmonary Fibrosis (IPF) is a chronic and progressive disease. Fibrosis is caused by aberrant alveolar epithelial cell activation and repair leading to fibroblastic foci, accumulation of extracellular matrix and irreversible destruction of the lung. The objective of this study was to develop a rat model of fibrosis using bleomycin. Mass Spectrometry Imaging (MSI) was used to identify biomarkers in fibrotic lesions.

Rats were dosed with one or seven doses of bleomycin delivered to the lungs. Control animals received vehicle. Body weights, clinical signs and respiratory parameters were monitored during the in-life phase. Lungs were fixed for histopathology (Day 21) or for mass spectrometry imaging (MALDI-FTICR) (Day 7 and Day 22). MSI was also used to confirm the distribution of bleomycin after dosing.

Bleomycin caused statistically significant changes in respiratory parameters and lung weights, as well as a reduction in body weight gain; all changes were consistent with the development of fibrosis. Histopathological analysis revealed multifocal fibrosis with inflammation. The extent of all changes was greater in those animals administered seven doses of bleomycin compared with one dose. MSI identified the significant upregulation of lipids in fibrotic lesions; some identified lipids are known to be associated with IPF (molecular species of lysophosphatidic acid)(Montesi et al BMC Pulm Med.27;14 2014) while other lipids were novel (with roles in cell signalling, chemotaxis and membrane stability).

In conclusion, we have identified a number of known and novel lipid biomarkers in fibrotic lesions in a characterized rat model of IPF induced by bleomycin administration.

  • Idiopathic pulmonary fibrosis
  • Biomarkers
  • Imaging
  • Copyright ©ERS 2015
Previous
Back to top
Vol 46 Issue suppl 59 Table of Contents
  • Table of Contents
  • Index by author
Email

Thank you for your interest in spreading the word on European Respiratory Society .

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Interstitial pulmonary fibrosis model develpment and identification of early biomarkers by MALDI imaging
(Your Name) has sent you a message from European Respiratory Society
(Your Name) thought you would like to see the European Respiratory Society web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
Interstitial pulmonary fibrosis model develpment and identification of early biomarkers by MALDI imaging
Mary Mcelroy, David Bonnel, Emeline Falaux, Gael Picard de Muller, Fabien Pamelard, Claudio Petterino, Stuart Naylor, Stephen Madden, Jonathan Stauber
European Respiratory Journal Sep 2015, 46 (suppl 59) PA4858; DOI: 10.1183/13993003.congress-2015.PA4858

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero

Share
Interstitial pulmonary fibrosis model develpment and identification of early biomarkers by MALDI imaging
Mary Mcelroy, David Bonnel, Emeline Falaux, Gael Picard de Muller, Fabien Pamelard, Claudio Petterino, Stuart Naylor, Stephen Madden, Jonathan Stauber
European Respiratory Journal Sep 2015, 46 (suppl 59) PA4858; DOI: 10.1183/13993003.congress-2015.PA4858
del.icio.us logo Digg logo Reddit logo Technorati logo Twitter logo CiteULike logo Connotea logo Facebook logo Google logo Mendeley logo

Jump To

  • Article
  • Info & Metrics
  • Tweet Widget
  • Facebook Like
  • Google Plus One

More in this TOC Section

  • Acute hyperoxic challenge improves haemodynamics & Pulmonary vascular stiffness in interstitial lung disease-associated pulmonary hypertension
  • Usual interstitial pneumonia preceding rheumatoid arthritis: Clinical, imaging, and histopathologic features
  • Serum surfactant protein D is a potential biomarker of lung damage in systemic sclerosis
Show more 1.5 Diffuse Parenchymal Lung Disease

Related Articles

Navigate

  • Home
  • Current issue
  • Archive

About the ERJ

  • Journal information
  • Editorial board
  • Reviewers
  • Press
  • Permissions and reprints
  • Advertising

The European Respiratory Society

  • Society home
  • myERS
  • Privacy policy
  • Accessibility

ERS publications

  • European Respiratory Journal
  • ERJ Open Research
  • European Respiratory Review
  • Breathe
  • ERS books online
  • ERS Bookshop

Help

  • Feedback

For authors

  • Instructions for authors
  • Publication ethics and malpractice
  • Submit a manuscript

For readers

  • Alerts
  • Subjects
  • Podcasts
  • RSS

Subscriptions

  • Accessing the ERS publications

Contact us

European Respiratory Society
442 Glossop Road
Sheffield S10 2PX
United Kingdom
Tel: +44 114 2672860
Email: journals@ersnet.org

ISSN

Print ISSN:  0903-1936
Online ISSN: 1399-3003

Copyright © 2022 by the European Respiratory Society